These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Distinct signaling pathways confer different vascular responses to VEGF 121 and VEGF 165. Zhang Y; Furumura M; Morita E Growth Factors; 2008 Jun; 26(3):125-31. PubMed ID: 18569020 [TBL] [Abstract][Full Text] [Related]
7. Soluble markers for the detection of hypoxia under antiangiogenic treatment. Drevs J Anticancer Res; 2003; 23(2A):1159-61. PubMed ID: 12820365 [TBL] [Abstract][Full Text] [Related]
8. Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma. Pang R; Poon RT Cancer Lett; 2006 Oct; 242(2):151-67. PubMed ID: 16564617 [TBL] [Abstract][Full Text] [Related]
9. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2. Chung TW; Kim SJ; Choi HJ; Kim KJ; Kim MJ; Kim SH; Lee HJ; Ko JH; Lee YC; Suzuki A; Kim CH Glycobiology; 2009 Mar; 19(3):229-39. PubMed ID: 18974200 [TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor. Kong D; Okamura M; Yoshimi H; Yamori T Eur J Cancer; 2009 Mar; 45(5):857-65. PubMed ID: 19144509 [TBL] [Abstract][Full Text] [Related]
11. Adrenomedullin stimulates angiogenic response in cultured human vascular endothelial cells: involvement of the vascular endothelial growth factor receptor 2. Guidolin D; Albertin G; Spinazzi R; Sorato E; Mascarin A; Cavallo D; Antonello M; Ribatti D Peptides; 2008 Nov; 29(11):2013-23. PubMed ID: 18692535 [TBL] [Abstract][Full Text] [Related]
12. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway. Jung MH; Lee SH; Ahn EM; Lee YM Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635 [TBL] [Abstract][Full Text] [Related]
13. Diabetes mellitus activates signal transduction pathways resulting in vascular endothelial growth factor resistance of human monocytes. Tchaikovski V; Olieslagers S; Böhmer FD; Waltenberger J Circulation; 2009 Jul; 120(2):150-9. PubMed ID: 19564559 [TBL] [Abstract][Full Text] [Related]
14. Non-redundant roles of the Gab1 and Gab2 scaffolding adapters in VEGF-mediated signalling, migration, and survival of endothelial cells. Caron C; Spring K; Laramée M; Chabot C; Cloutier M; Gu H; Royal I Cell Signal; 2009 Jun; 21(6):943-53. PubMed ID: 19233262 [TBL] [Abstract][Full Text] [Related]
15. The role of c-Fes in vascular endothelial growth factor-A-mediated signaling by endothelial cells. Kanda S; Mochizuki Y; Miyata Y; Kanetake H Biochem Biophys Res Commun; 2003 Jul; 306(4):1056-63. PubMed ID: 12821150 [TBL] [Abstract][Full Text] [Related]
16. Combined targeting of EGFR-dependent and VEGF-dependent pathways: rationale, preclinical studies and clinical applications. Tortora G; Ciardiello F; Gasparini G Nat Clin Pract Oncol; 2008 Sep; 5(9):521-30. PubMed ID: 18594498 [TBL] [Abstract][Full Text] [Related]
17. Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of alpha-difluoromethylornithine (DFMO) in breast cancer cells. Xu H; Washington S; Verderame MF; Manni A Breast Cancer Res Treat; 2008 Nov; 112(2):255-61. PubMed ID: 18097746 [TBL] [Abstract][Full Text] [Related]